Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Mi Yang

2 papers in the library · publishing 2025-2026

Papers

Effect of meditation on clinical symptoms and gray matter volume in chronic schizophrenia: a randomized controlled trial.

European Archives of Psychiatry and Clinical Neuroscience May 19, 2026 Mi Yang, Yuzheng Ma, Jialong Huang et al.

Meditation therapy can slow the loss of gray matter volume in the brains of people with chronic schizophrenia. In an eight-month trial with 58 male inpatients, those who practiced meditation showed less brain tissue shrinkage than those receiving conventional treatment alone. Greater preservation of gray matter in the right thalamus was linked to larger reductions in positive, negative, and total symptom scores on the PANSS scale. Similar links were found for the right insula and supplementary motor area. The results suggest meditation may help alleviate clinical symptoms in schizophrenia by protecting brain structure.

The efficacy of meditation on insula dysfunction in patients with chronic schizophrenia.

Frontiers in Psychiatry January 1, 2025 Di Kong, Shoukang Zou, Yanqing Huang et al.

In chronic schizophrenia patients, eight months of meditation combined with antipsychotic medication improved overall psychiatric symptoms (PANSS scores) and restored abnormal dynamic functional connectivity between insula subregions (left dorsal anterior insula and left posterior insula) and the right orbital part of the inferior frontal gyrus, compared to baseline. At baseline, patients showed significantly lower global functional connectivity in several brain regions than healthy controls. However, cognitive function (RBANS scores) did not significantly change. The findings suggest meditation can enhance neural circuit function in schizophrenia, supporting its clinical use.